← United States · Coverage record
US · SEC FORM 4
Prestige Consumer Healthcare Inc.
PBH · NYSE · CIK 0001295947 · Healthcare · Drug Manufacturers—Specialty & Generic
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
37 Form 4 transaction lines observed in the same window
4 sales · 33 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 4,644,472
- Previous report
- 4,794,058
- Avg daily volume
- 703,849
- Days to cover
- 6.6
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
No qualifying code P equity purchase is present in the local Form 4 history.
Form 4 evidence
42 transaction lines in the latest 365-day window; 378 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-04 | ZIER DAWN M. | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-04 | Kelly John F. | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-04 | DArecca James | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-04 | ZIER DAWN M. | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-04 | Kelly John F. | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-04 | DArecca James | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-04 | Clark Celeste A. | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-04 | BYOM JOHN E | Award / grant (A) | Common Stock, par value $0.01 per share | 2,981 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-11 | Zerillo Jeffrey | Sale (S) | Common Stock, par value $0.01 per share | 351 | USD 52.28 | USD 18,350 | SEC filing ↗ |
| 2026-05-07 | Zerillo Jeffrey | Sale (S) | Common Stock, par value $0.01 per share | 305 | USD 54.36 | USD 16,580 | SEC filing ↗ |
| 2026-05-07 | Zerillo Jeffrey | Tax withholding (F) | Common Stock, par value $0.01 per share | 351 | USD 54.59 | USD 19,161 | SEC filing ↗ |
| 2026-05-07 | Sacco Christine | Tax withholding (F) | Common Stock, par value $0.01 per share | 991 | USD 54.59 | USD 54,099 | SEC filing ↗ |
| 2026-05-07 | Mekhail Adel | Tax withholding (F) | Common Stock, par value $0.01 per share | 487 | USD 54.59 | USD 26,585 | SEC filing ↗ |
| 2026-05-07 | Lombardi Ronald M. | Tax withholding (F) | Common Stock, par value $0.01 per share | 2,543 | USD 54.59 | USD 138,822 | SEC filing ↗ |
| 2026-05-05 | Zerillo Jeffrey | Sale (S) | Common Stock, par value $0.01 per share | 1,207 | USD 54.99 | USD 66,373 | SEC filing ↗ |
| 2026-05-05 | Zerillo Jeffrey | Tax withholding (F) | Common Stock, par value $0.01 per share | 307 | USD 55.75 | USD 17,115 | SEC filing ↗ |
| 2026-05-05 | Sacco Christine | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,267 | USD 55.75 | USD 70,635 | SEC filing ↗ |
| 2026-05-05 | Lombardi Ronald M. | Tax withholding (F) | Common Stock, par value $0.01 per share | 2,197 | USD 55.75 | USD 122,483 | SEC filing ↗ |
| 2026-05-05 | Zerillo Jeffrey | Sale (S) | Common Stock, par value $0.01 per share | 346 | USD 55.32 | USD 19,141 | SEC filing ↗ |
| 2026-05-04 | Zerillo Jeffrey | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,243 | USD 55.31 | USD 68,750 | SEC filing ↗ |
| 2026-05-04 | Zerillo Jeffrey | Award / grant (A) | Common Stock, par value $0.01 per share | 5,307 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Sacco Christine | Tax withholding (F) | Common Stock, par value $0.01 per share | 3,434 | USD 55.31 | USD 189,935 | SEC filing ↗ |
| 2026-05-04 | Sacco Christine | Award / grant (A) | Common Stock, par value $0.01 per share | 18,984 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | P'Pool William | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,888 | USD 55.31 | USD 104,425 | SEC filing ↗ |
| 2026-05-04 | P'Pool William | Award / grant (A) | Common Stock, par value $0.01 per share | 7,862 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Mekhail Adel | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,695 | USD 55.31 | USD 93,750 | SEC filing ↗ |
| 2026-05-04 | Mekhail Adel | Award / grant (A) | Common Stock, par value $0.01 per share | 7,519 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Lombardi Ronald M. | Tax withholding (F) | Common Stock, par value $0.01 per share | 16,789 | USD 55.31 | USD 928,600 | SEC filing ↗ |
| 2026-05-04 | Lombardi Ronald M. | Award / grant (A) | Common Stock, par value $0.01 per share | 51,130 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-02 | Sacco Christine | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,091 | USD 55.09 | USD 60,103 | SEC filing ↗ |
| 2026-05-02 | Zerillo Jeffrey | Tax withholding (F) | Common Stock, par value $0.01 per share | 432 | USD 55.09 | USD 23,799 | SEC filing ↗ |
| 2026-05-02 | Sacco Christine | Tax withholding (F) | Common Stock, par value $0.01 per share | 1,091 | USD 55.09 | USD 60,103 | SEC filing ↗ |
| 2026-05-02 | P'Pool William | Tax withholding (F) | Common Stock, par value $0.01 per share | 599 | USD 55.09 | USD 32,999 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | PBH |
| CIK | 0001295947 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 378 transaction lines from 2020-05-04 to 2026-08-04 0 P purchase lines · 61 S sale lines · 317 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.